CML in blast crisis: more common than we think?
- PMID: 28522462
- DOI: 10.1182/blood-2017-04-776369
CML in blast crisis: more common than we think?
Conflict of interest statement
Conflict-of-interest disclosure: S.P.H. has received honoraria from Amgen, Jazz Pharmaceuticals, and Erytech and consulting fees from Novartis.
Comment on
-
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology.Blood. 2017 May 18;129(20):2771-2781. doi: 10.1182/blood-2016-11-749978. Epub 2017 Mar 22. Blood. 2017. PMID: 28331056
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials